ProShares UltraShort NASDAQ Biotechnology
6 hedge funds and large institutions have $859K invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
–
Calls
$2K
Puts
$21K
Net Calls
-$19K
Net Calls Change
–
Top Buyers
| 1 |
1
IMC Chicago
Chicago,
Illinois
|
$443K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$224K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$187K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$247 |
| 2 |
2
Morgan Stanley
New York
|
$2.87K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
IMC Chicago
Chicago,
Illinois
| $443K | 25,210 | +10,209 | +68% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $224K | 12,728 | +8,007 | +170% |
|
|
3
Citadel Advisors
Miami,
Florida
| $187K | 10,649 | +624 | +6% |
|
|
4
Morgan Stanley
New York
| $2.87K | 163 | -161 | -50% |
|
5
Citigroup
New York
| $1.49K | 85 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $247 | 14 | -259 | -95% |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|